HealthSeptember 03, 2024

From risk to resilience: Drug diversion programs in action

Experts agree most drug diversion goes unseen, is underreported, and is under-investigated, contributing to significant patient and staff safety risks. So how are hospitals addressing diversion prevention?

Experts agree most drug diversion goes unseen, is underreported, and is under-investigated, contributing to significant patient and staff safety risks. So how are hospitals addressing diversion prevention? This discussion highlighted essential strategies and challenges in building effective prevention programs.

Hospitals and health systems manage drug diversion prevention and mitigation in various ways; there is no one-size-fits-all approach to establishing an effective program. In this webinar, industry experts share best practices on how to assess and manage a successful drug diversion prevention program and share real-world examples of practices they’ve implemented in their programs. 

In this webinar, our speakers discuss: 

  • Key building blocks to consider before implementing a drug diversion prevention program
  • Best practices for assessing drug diversion risk, detecting diversion, and investigating potential diversion. 
  • How their pharmacy teams streamline diversion investigation and reporting

Speakers: 

  • Bethanie Gamble, PharmD, Diversion Coordinator – Upstate, Prisma Health
  • Samantha Roberts, PharmD, MBA, Corporate Director of Pharmacy Regulatory and Compliance, Emory Healthcare Inc.

This webinar offers valuable guidance on implementing resilient drug diversion program through effective use of technology, strategic resource allocation, and fostering a culture of accountability and awareness.

Access on-demand webinar

Gordon Watkins
Specialized Consulting Manager
Dr. Gordon Watkins has over 8 years of experience in institutional pharmacy clinical practice and operations, most specifically in implementing and optimizing pharmacy technology solutions.
Back To Top